CAHIC(SH:600195) Xin Lang Zheng Quan·2026-02-24 05:55Core Viewpoint - Zhongmu Co., Ltd. has shown a mixed performance in stock price and financial results, with a slight decline in stock price year-to-date but significant growth in revenue and net profit for the first nine months of 2025 [1][2]. Financial Performance - As of September 30, 2025, Zhongmu Co., Ltd. achieved a revenue of 4.442 billion yuan, representing a year-on-year growth of 6.32% [2]. - The net profit attributable to shareholders reached 225 million yuan, marking a substantial increase of 175.49% compared to the previous year [2]. Stock Market Activity - On February 24, Zhongmu Co., Ltd. saw its stock price rise by 2.09%, reaching 7.83 yuan per share, with a trading volume of 63.725 million yuan and a turnover rate of 0.80% [1]. - The company has experienced a year-to-date stock price decline of 0.51%, with a 5-day drop of 1.26%, a 20-day drop of 7.77%, and a 60-day drop of 0.13% [1]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 6.45% to 36,900, while the average number of tradable shares per person increased by 6.90% to 27,706 shares [2]. - The top ten circulating shareholders include notable entities such as Guotai Junan Zhongzheng Livestock Breeding ETF and Hong Kong Central Clearing Limited, with varying changes in their holdings [3]. Business Overview - Zhongmu Co., Ltd. specializes in animal health products, including vaccines, diagnostic liquids, and veterinary drugs, with its main business revenue composition being: chemical drugs (35.78%), trade (27.87%), feed (19.21%), and biological products (16.10%) [1]. - The company is classified under the agricultural and animal husbandry sector, specifically in animal health [1].